Touko Inao

Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo

Miki Tongu, Nanae Harashima, Hiroyuki Monma et al. · Cancer Immunology Immunotherapy · 2012 · 114 citations · Full text

Cancer Immunosurveillance, Oncology, Low-dose Cyclophosphamide +10

Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin

Touko Inao, Yuichi Iida, Tamami Moritani et al. · Oncotarget · 2018 · 74 citations · Full text

Breast Oncology, Apoptosis, Immunology +17

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study

Hirotaka Iwase, Yutaka Yamamoto, Mutsuko Yamamoto‐Ibusuki et al. · British Journal of Cancer · 2013 · 53 citations · Full text

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer

Mai Tomiguchi, Yutaka Yamamoto, Mutsuko Yamamoto‐Ibusuki et al. · Cancer Science · 2016 · 51 citations · Full text

Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer

Touko Inao, Nanae Harashima, Hiroyuki Monma et al. · Breast Cancer Research and Treatment · 2011 · 46 citations

Breast Oncology, Cytoplasmic Delivery, Medicine +11